Edition:
India

VistaGen Therapeutics Inc (VTGN.OQ)

VTGN.OQ on NASDAQ Stock Exchange Capital Market

1.38USD
20 Jul 2018
Change (% chg)

$0.02 (+1.47%)
Prev Close
$1.36
Open
$1.38
Day's High
$1.38
Day's Low
$1.35
Volume
17,020
Avg. Vol
119,479
52-wk High
$2.65
52-wk Low
$0.69

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.191
Dec 0.00 -0.250
Sep 0.00 -0.531
Jun 0.00 -0.278
FY 2017 Mar '17 0.00 -0.325
Dec 1.25 -0.343
Sep 0.00 -0.416
Jun 0.00 -0.514
FY 2016 Mar '16 0.00 -4.445
Dec 0.00 -1.952
Sep 0.00 -5.263
Jun 0.00 -19.233
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 1 0.00 0.00 0.00 --
Quarter Ending Mar-19 1 0.00 0.00 0.00 --
Year Ending Mar-18 2 0.00 0.00 0.00 --
Year Ending Mar-19 1 0.00 0.00 0.00 0.00
Year Ending Mar-20 1 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 1 -0.14 -0.14 -0.14 -0.23
Quarter Ending Mar-18 1 -0.28 -0.28 -0.28 --
Year Ending Mar-18 2 -1.58 -1.08 -2.08 --
Year Ending Mar-19 3 -1.18 -0.56 -1.89 -0.90
Year Ending Mar-20 3 -1.35 -0.59 -2.03 -0.86
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 30.93 32.76
P/E High - Last 5 Yrs. -- 40.66 45.44
P/E Low - Last 5 Yrs. -- 23.70 24.26
Beta -0.57 0.90 0.89
Price to Sales (TTM) 13.68 3.94 5.73
Price to Book (MRQ) -- 4.88 5.47
Price to Tangible Book (MRQ) -- 5.70 7.05
Price to Cash Flow (TTM) -- 22.85 23.29
% Owned Institutions 18.15 1.23 2.21

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.51
Dividend Yield - 5 Year Avg -- 1.58 1.52
Dividend 5 Year Growth Rate -- 4.35 5.22
Payout Ratio(TTM) -- 45.85 43.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 2.28 8.01
Sales (TTM) vs TTM 1 Yr. Ago -- 4.77 5.64
Sales - 5 Yr. Growth Rate -1.41 9.94 10.18
EPS (MRQ) vs Qtr. 1 Yr. Ago 45.84 17.61 20.60
EPS (TTM) vs TTM 1 Yr. Ago 88.82 -- --
EPS - 5 Yr. Growth Rate -- 9.75 10.66
Capital Spending - 5 Yr. Growth Rate 49.14 15.37 15.33

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.22
Current Ratio (MRQ) 2.12 2.94 3.03
LT Debt to Equity (MRQ) -- 10.03 12.51
Total Debt to Equity (MRQ) -- 14.07 16.84
Interest Coverage (TTM) -5,804.00 35.78 32.64

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 54.72 54.37
Gross Margin - 5 Yr. Avg. -- 52.10 52.17
EBITD Margin (TTM) -838.44 -- --
EBITD - 5 Yr. Avg -3,202.01 18.50 10.81
Operating Margin (TTM) -843.66 14.31 4.58
Operating Margin - 5 Yr. Avg. -5,471.17 14.45 6.23
Pre-Tax Margin (TTM) -844.10 14.80 5.43
Pre-Tax Margin - 5 Yr. Avg. -6,012.32 14.86 6.67
Net Profit Margin (TTM) -844.30 11.05 1.73
Net Profit Margin - 5 Yr. Avg. -6,013.25 11.16 2.94
Effective Tax Rate (TTM) -- 23.22 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.49 23.98

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 953,055,695 860,394,083
Net Income/Employee (TTM) -- 112,126,539 101,209,433
Receivable Turnover (TTM) -- 5.72 5.87
Inventory Turnover (TTM) -- 2.63 3.41
Asset Turnover (TTM) 0.22 0.96 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -188.55 11.58 11.14
Return on Assets - 5 Yr. Avg. -1,968.05 12.95 12.40
Return on Investment (TTM) -245.77 15.07 14.61
Return on Investment - 5 Yr. Avg. -- 16.90 16.14
Return on Equity (TTM) -415.24 16.60 16.34
Return on Equity - 5 Yr. Avg. -- 17.97 17.40
  1 Year 3 Year 5 Year
Sales % -- -- -1.41
EPS (TTM) % 94.69 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for VistaGen Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.39%
# of Holders: 20
Total Shares Held: 3,084,475
3 Mo. Net Change: -21,000
# New Positions: 0
# Closed Positions: 0
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.